Clinical Trial: A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Parkinson's Disease Psychosis
Study Type: INTERVENTIONAL
Official Title: A Multi-Center, Placebo-Controlled, Double-Blind Trial to Examine the Safety and Efficacy of Pimavanserin in the Treatment of Psychosis in Parkinson's Disease
Brief Summary:
The purpose of this study is to evaluate the safety and efficacy of 34 mg pimavanserin compared to placebo in patients with Parkinson's disease psychosis (PDP).
Read more